iAnthus Q3: Revenue Growth Clashes with 280E Tax Trap and Auditor Shakeup

NEW YORK – November 12, 2026 – In the highly regulated and deeply fragmented U.S. cannabis industry, top-line growth often masks underlying structural vulnerabilities. For iAnthus Capital Holdings, Inc. (CSE: IAN, OTCID: ITHUF), the third quarter of 2026 serves as a textbook example of this paradox. The vertically integrated multi-state operator (MSO) reported sequential revenue gains and expanded Adjusted EBITDA. Yet, beneath these operational wins lies a precarious financial reality, punctuated by a crushing federal tax burden, a persistent net loss, and a sudden change in its independent auditing firm.

As companies across the sector attempt to leverage operational efficiencies and optimized retail footprints to accelerate growth, they remain tethered to legacy liabilities and punitive regulatory frameworks. The latest financial disclosures from iAnthus provide a critical lens into the strategic balancing act required to navigate an industry where generating millions in gross profit still leaves a business deep in the red.

Operational Growth Meets Financial Fragility

From an operational standpoint, iAnthus demonstrated clear momentum in the third quarter. The company generated $38.4 million in revenue, representing an 8.5% sequential increase from the $35.3 million reported in the second quarter of 2026, and an 8.4% year-over-year improvement. This top-line expansion suggests that the company’s strategic refocusing on key growth markets—including Florida, Maryland, New Jersey, Massachusetts, and New York—is yielding tangible consumer traction.

Gross profit reached $16.7 million, though the gross margin experienced a sequential compression of 209 basis points, landing at 43.5%. This margin contraction is not unique to iAnthus; it reflects broader industry pricing pressures as increased cultivation capacity and fierce competition in mature markets force operators to sacrifice margin for volume.

However, the operational narrative takes a sharp turn when examining the bottom line. Despite the revenue growth, iAnthus reported a net loss of $13.2 million for the quarter. While this is a moderate improvement compared to the $14.4 million loss in Q2 2026, it remains wider than the $12.5 million deficit recorded in the same quarter last year.

The disparity between top-line growth and bottom-line hemorrhage highlights the financial fragility that continues to plague mid-tier MSOs. Adjusted EBITDA—a metric heavily favored by cannabis operators to showcase operational cash flow by stripping out one-time and non-cash items—rose to $5.2 million, up from $4.4 million sequentially. Yet, as strategic analysts are quick to note, Adjusted EBITDA does not pay the bills. The company’s persistent working capital deficiencies, which stood at a staggering $232.7 million earlier in the year, and ongoing cash burn rates cast a long shadow over its operational achievements. The inclusion of a going concern explanatory paragraph in the Q3 10-Q filing underscores the severity of these liquidity constraints, signaling substantial doubt about the entity's ability to survive the next twelve months without significant capital restructuring.

The 280E Tax Trap: A Structural Stranglehold

To understand why a company generating nearly $17 million in gross profit is losing $13 million a quarter, one must look directly at the federal tax code—specifically, Internal Revenue Code (IRC) Section 280E. This archaic provision prevents state-legal cannabis businesses from deducting ordinary business expenses from their gross income, resulting in effective tax rates that would bankrupt traditional enterprises.

In Q3 2026, iAnthus incurred a staggering $7.0 million in income tax expense. This figure is nearly identical to the $7.03 million incurred in Q2 and double the $3.4 million from the same period in 2025. Crucially, this tax bill is levied against a pre-tax operating deficit. The company is effectively being taxed on phantom income, a structural stranglehold that drains vital cash reserves that could otherwise be deployed toward debt service or strategic growth initiatives.

Compounding the 280E tax trap is the company's heavy debt burden. Because federal prohibition locks cannabis operators out of traditional commercial banking, companies like iAnthus have historically relied on expensive, alternative financing. In the third quarter alone, the company paid $4.3 million in net interest expense. When combined with the $7.0 million tax provision and $5.5 million in depreciation and amortization, the company's $16.7 million gross profit is entirely obliterated before a single dollar reaches the bottom line.

For industry observers, this dynamic illustrates the fundamental disconnect between cannabis operations and cannabis finance. Until federal reform deschedules cannabis or provides explicit relief from Section 280E, operators will continue to run on a treadmill, forced to achieve extraordinary operational scale just to break even on a net income basis.

Auditor Shakeup: Red Flag or Routine Realignment?

Adding a layer of complexity to the Q3 earnings release was the sudden announcement of an auditor transition. Effective November 12, 2026, iAnthus announced the resignation of its independent registered public accounting firm, PKF O'Connor Davies, LLP (PKFOD), and the immediate appointment of Macias Gini & O'Connell LLP (MGO).

In corporate governance, sudden auditor changes—especially those occurring immediately after a quarterly filing—inevitably raise eyebrows among institutional investors and regulatory observers. The company’s disclosures emphasize that there were no disagreements with PKFOD regarding accounting principles, financial statement disclosures, or auditing scope during the three most recent fiscal years.

However, the transition cannot be viewed in a vacuum. PKFOD’s audit opinions for fiscal years 2023 through 2025 consistently carried explanatory going-concern paragraphs. More critically, the company has a documented history of material weaknesses in its internal controls over financial reporting during those same years.

From a strategic perspective, bringing in MGO—a firm with a robust footprint in the cannabis sector—could be interpreted as a proactive move by the audit committee and the recently appointed CFO, Jason Ware, to turn the page on historical governance struggles. A fresh set of eyes may help the company streamline its financial reporting infrastructure as it attempts to execute a complex turnaround. Conversely, skeptics may view the departure of a long-standing auditor amid persistent going-concern warnings as a red flag, signaling the immense pressure placed on accounting firms tasked with signing off on the financials of highly leveraged, cash-burning cannabis operators.

Strategic Imperatives and the Path Forward

Navigating this multifaceted crisis requires aggressive business innovation and ruthless capital allocation. iAnthus is actively attempting to engineer a turnaround through strategic asset divestments, aiming to shed underperforming operations to pay down debt and bolster its balance sheet. The proceeds are being redirected toward high-potential markets where the company can achieve localized economies of scale.

Additionally, the company has sought to optimize its cash position where possible, evidenced by the $424,000 in other income reported this quarter, largely derived from accounts payable write-offs, vendor credits, and Employee Retention Tax Credits. While these are one-time benefits, they reflect a management team scraping for every available dollar of liquidity. The securing of a $2.5 million revolving line of credit earlier in the year further highlights the ongoing scramble for working capital.

Ultimately, the third quarter of 2026 encapsulates the broader narrative of the U.S. cannabis industry. The consumer demand is undeniable, as evidenced by the company's resilient revenue streams and successful brand portfolio, which includes MPX, Anthologie, and Black Label. The operational know-how to cultivate, produce, and sell at scale is clearly present. Yet, the financial architecture supporting these operations remains fundamentally compromised by federal tax laws and expensive capital.

For business leaders and investors watching the space, iAnthus serves as a real-time stress test. The company's ability to stave off its going-concern risks will depend less on selling more cannabis and more on its strategic ability to restructure debt, eliminate internal control weaknesses, and survive long enough for the regulatory environment to finally catch up with the economic reality of the industry.